Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.	type 2 diabetes mellitus	Recruiting	Phase 4	2025-06-13		NCT07019012

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Huazhong University of Science and Technology	83
Renmin Hospital of Wuhan University	73
Taihe Hospital	18
The First Affiliated Hospital of Nanchang University	84
Wuhan Central Hospital	22
Xiangyang No.1 People's Hospital	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Wuhan University People's Hospital	Wuhan	China	2

Clinical trials